Vietnam Bird Flu Vaccine Trial Gives Volunteers Second Shots
This article was originally published in PharmAsia News
Executive Summary
Vietnam's clinical trial of its H5N1 vaccine took another step as the 30 military volunteers were given their second injections. The head of the Military Medical Academy, whose recruits are participating in the trial, said the institute's researchers would recommend using more academy volunteers for the next phase if the vaccine appears to be efficacious. Vietnam's National Institute of Hygiene and Epidemiology's Company for Vaccine and Biological Production No. 1, the drug's maker, expects to put the vaccine on the market next year at a cost of $1.88 per shot. (Click here for more
You may also be interested in...
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.